Advanced in Chlamydia

Charles J. Cazanave

Bordeaux, FR 
Advanced in Chlamydia
Bordeaux, FR 
OverviewLocationsClinical Research

Overview

Charles Cazanave practices in Bordeaux, France. Mr. Cazanave is rated as an Advanced expert by MediFind in the treatment of Chlamydia. His top areas of expertise are HIV/AIDS, Pelvic Inflammatory Disease, Lymphogranuloma Venereum, Whipple Disease, and Intrauterine Device Insertion.

His clinical research consists of co-authoring 134 peer reviewed articles and participating in 4 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 7 articles in the study of Chlamydia.

Gender
Male

Locations

Bordeaux, France
Other Locations
Place Amélie Raba Léon 33000 Bordeaux, Place, 33000, France
CHU Bordeaux
Pessac-sur-dordogne, France

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

Prevention of COVID-19 Complications in High-risk Subjects Infected by SARS-CoV-2 and Eligible for Treatment Under a Cohort ATU ('Autorisation Temporaire d'Utilisation') or or Authorisation for Early Access (AAP). A Prospective Cohort.
Prevention of COVID-19 Complications in High-risk Subjects Infected by SARS-CoV-2 and Eligible for Treatment Under a Cohort ATU ('Autorisation Temporaire d'Utilisation') or or Authorisation for Early Access (AAP). A Prospective Cohort.
Enrollment Status: Completed
Publish Date: May 28, 2025
Intervention Type: Other
Aging With HIV and Neurocognitive Decline, a Follow-up Study
Aging With HIV and Neurocognitive Decline, a Follow-up Study
Enrollment Status: Completed
Publish Date: January 30, 2025
Intervention Type: Other
Study Phase: Not Applicable
A Phase IIIb, Randomized, Multicenter, Active-controlled, Parallel-group, Non-inferiority, Open-label Study Evaluating the Efficacy, Safety, and Tolerability of Switching to Long-acting Cabotegravir Plus Long-acting Rilpivirine Administered Every Two Months From a Bictegravir/Emtricitabine/Tenofovir Alafenamide Single Tablet Regimen in HIV-1 Infected Adults Who Are Virologically Suppressed
A Phase IIIb, Randomized, Multicenter, Active-controlled, Parallel-group, Non-inferiority, Open-label Study Evaluating the Efficacy, Safety, and Tolerability of Switching to Long-acting Cabotegravir Plus Long-acting Rilpivirine Administered Every Two Months From a Bictegravir/Emtricitabine/Tenofovir Alafenamide Single Tablet Regimen in HIV-1 Infected Adults Who Are Virologically Suppressed
Enrollment Status: Completed
Publish Date: June 04, 2024
Intervention Type: Drug
Study Drugs: Cabotegravir, Rilpivirine, BIKTARVY
Study Phase: Phase 3
Sexual Hepatitis C in HIV Positive Men Who Have Sex With Men (MSM) in Bordeaux
Sexual Hepatitis C in HIV Positive Men Who Have Sex With Men (MSM) in Bordeaux
Enrollment Status: Completed
Publish Date: November 14, 2018
Intervention Type: Behavioral
View 3 Less Clinical Trials

134 Total Publications

Prevention and management of syphilis in pregnant and perinatal women.
Prevention and management of syphilis in pregnant and perinatal women.
Journal: Infectious diseases now
Published: September 15, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Cazanave's expertise for a condition
ConditionClose
      View All 8 Advanced Conditions
      View All 48 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile